The course of metastatic prostate cancer under treatment
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://link.springer.com/content/pdf/10.1186/2193-1801-3-725.pdf
Reference29 articles.
1. Andrew T, Tuckey J, Rice M: Orchidectomy following failure of antiandrogen monotherapy in patients with metastatic prostate cancer. Eur Urol 2001, 40: 130-134. 10.1159/000049762
2. Caubet JF, Tosteson TD, Dong EW, Naylon EM, Whiting GW, Ernstoff MS, Ross SD: Maximum androgen blockade in advanced prostate cancer: a meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens. Urology 1997, 49: 71-78. 10.1016/S0090-4295(96)00325-1
3. Chen Y, Sawyers CL, Scher HI: Targeting the androgen receptor pathway in prostate cancer. Curr Opin Pharmacol 2008, 8: 440-448. 10.1016/j.coph.2008.07.005
4. Chi KN, Bjartell A, Dearnaley D, Saad F, Schroder FH, Sternberg C, Tombal B, Visakorpi T: Castration-resistant prostate cancer: from new pathophysiology to new treatment targets. Eur Urol 2009, 56: 594-605. 10.1016/j.eururo.2009.06.027
5. Crawford E, Eisenberger M, McLeod DG, Spaulding JT, Benson R, Dorr FA, Blumenstein BA, Davis MA, Gutman PJ: A controlled randomized trial of leuprolid with and without flutamide in prostatic cancer. N Eng J Med 1989, 321: 419-424. 10.1056/NEJM198908173210702
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Characteristics, properties, and analytical and bio‐analytical methods of enzalutamide: A review;SEPARATION SCIENCE PLUS;2023-02-07
2. Bilateral Orchidectomy Revisited in Management of Metastatic Hormone-Sensitive Prostate Cancer;Indian Journal of Surgical Oncology;2021-07-24
3. Bardoxolone-Methyl (CDDO-Me) Suppresses Androgen Receptor and Its Splice-Variant AR-V7 and Enhances Efficacy of Enzalutamide in Prostate Cancer Cells;Antioxidants;2020-01-12
4. Prostate Neoplasm;Blandy's Urology;2019-02-27
5. Sulforaphane increases the efficacy of anti-androgens by rapidly decreasing androgen receptor levels in prostate cancer cells;International Journal of Oncology;2016-08-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3